For this pilot study, we chose patients in Tangdu Hospital and Xi’an Gaoxin Hospital with limb motor dysfunction caused by stroke 15-180 days after the onset (recovery period) and requiring rehabilitation training.
Patient inclusion criteria were as follows: (1) stroke diagnosed by computed tomography or magnetic resonance imaging within 90 days; (2) age between 30 and 75 years, male or female; (3) stable rehabilitation patients with limb motor dysfunction (with hemiplegic motor function evaluated according to the Brunnstrom upper or lower extremity grading stages II-VI) caused by stroke 15-180 days after its onset (recovery period); (4) cognition is clear and can follow the research protocol; (5) the patient can understand the study’s purpose, as well as showing sufficient compliance with the study protocol and signed the informed consent.
The following patients were excluded: (1) significant impairment of cognition and consciousness so that the Fugl-Meyer test could not be completed, (2) other significant limb lesions, such as fractures, severe arthritis, or amputation; (3) formation of limb joint contractures; (4) patients with disability, as specified by the International Classification of Functioning, Disability, and Health; (5) patients with a combination of severe primary diseases involving the cardiovascular, liver, kidney, and hematopoietic systems and mentally ill patients, as well as other circumstances that the investigator considers inappropriate to participate in this trial.
Patient inclusion criteria were as follows: (1) stroke diagnosed by computed tomography or magnetic resonance imaging within 90 days; (2) age between 30 and 75 years, male or female; (3) stable rehabilitation patients with limb motor dysfunction (with hemiplegic motor function evaluated according to the Brunnstrom upper or lower extremity grading stages II-VI) caused by stroke 15-180 days after its onset (recovery period); (4) cognition is clear and can follow the research protocol; (5) the patient can understand the study’s purpose, as well as showing sufficient compliance with the study protocol and signed the informed consent.
The following patients were excluded: (1) significant impairment of cognition and consciousness so that the Fugl-Meyer test could not be completed, (2) other significant limb lesions, such as fractures, severe arthritis, or amputation; (3) formation of limb joint contractures; (4) patients with disability, as specified by the International Classification of Functioning, Disability, and Health; (5) patients with a combination of severe primary diseases involving the cardiovascular, liver, kidney, and hematopoietic systems and mentally ill patients, as well as other circumstances that the investigator considers inappropriate to participate in this trial.
Free full text: Click here
